<DOC>
	<DOCNO>NCT02007915</DOCNO>
	<brief_summary>To determine safety effectiveness pamidronate patient radiographically proven avascular necrosis result unstable ( acute ) slip capital femoral epiphysis , traumatic proximal femur fracture , traumatic hip dislocation , idiopathic nature .</brief_summary>
	<brief_title>The Use Bisphosphonates Treatment Avascular Necrosis Femoral Head</brief_title>
	<detailed_description>Avascular necrosis femoral head collapse devastate condition pediatric patient population lead degenerative arthritis significant disability . Bisphosphonate therapy show effective treatment adult avascular necrosis femoral head . For child adolescent however , currently effective treatment prevents collapse femoral head . Some patient prove avascular necrosis femoral epiphysis treat bisphosphonates ( intravenous pamidronate ) The Hospital Sick Children . The main aim study prospectively collect data HSC patient receive bisphosphonate treatment thereby report effectiveness treatment prevention femoral head collapse .</detailed_description>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Osteonecrosis</mesh_term>
	<mesh_term>Femur Head Necrosis</mesh_term>
	<mesh_term>Pamidronate</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Patients age 10 18 : unstable slip capital femoral epiphysis ( defined inability bear weight ) acute slip capital femoral epiphysis ( define separation epiphysis metaphysis proximal femur ) pin either situ follow reduction , traumatic hip dislocation traumatic proximal femur fracture , `` idiopathic '' avascular necrosis femoral head include unknown cause well Sickle Cell Disease , post radiation use , post chemotherapy treatment , post steroid treatment . Decline participate study . ( Patients still offer therapy whether wish include official study protocol . Clinical evaluation , laboratory imaging test would unchanged choose treat intravenous pamidronate ) Significant femoral head collapse judge radiographically treat surgeon Idiopathic cause age 10 .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Adolescent</keyword>
	<keyword>Avascular Necrosis</keyword>
	<keyword>Bisphosphonates</keyword>
	<keyword>Pamidronate</keyword>
</DOC>